Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$753M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$711M |
| 3 |
Humana
HUM
|
+$617M |
| 4 |
NextEra Energy
NEE
|
+$610M |
| 5 |
British American Tobacco
BTI
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.32B |
| 2 |
STJ
St Jude Medical
STJ
|
+$690M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$629M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$609M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$603M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.39% |
| 2 | Technology | 9.09% |
| 3 | Healthcare | 7.39% |
| 4 | Energy | 7.04% |
| 5 | Consumer Discretionary | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6426
Veru
VERU
$35.5M
| $17K | ﹤0.01% |
1,683
-55
| -3% | -$569 |
|
6427
CALL
Vanda Pharmaceuticals
VNDA
$307M
| $17K | ﹤0.01% |
1,200
-12,000
| -91% | -$171K |
|
6428
PUT
Vuzix
VUZI
$182M
| $17K | ﹤0.01% |
2,700
-1,900
| -41% | -$12.3K |
|
6429
PUT
Ziff Davis
ZD
$2B
| $17K | ﹤0.01% |
230
-4,715
| -95% | -$345K |
|
|
SRNE
6430
CALL
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $17K | ﹤0.01% |
4,200
-600
| -13% | -$3.01K |
|
|
AMPE
6431
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $17K | ﹤0.01% |
+69
| New | +$18.5K |
|
|
LOGM
6432
PUT
DELISTED
LogMein, Inc.
LOGM
| $17K | ﹤0.01% |
+170
| New | +$16.9K |
|
|
VII
6433
DELISTED
Vicon Industries, Inc.
VII
| $17K | ﹤0.01% |
47,169
-407
| -0.9% | -$197 |
|
6434
CALL
AMN Healthcare
AMN
$1.35B
| $16K | ﹤0.01% |
400
-300
| -43% | -$11.8K |
|
6435
Aemetis
AMTX
$106M
| $16K | ﹤0.01% |
12,598
-2,914
| -19% | -$4.04K |
|
6436
CALL
AdvanSix
ASIX
$545M
| $16K | ﹤0.01% |
584
-8,424
| -94% | -$218K |
|
|
CIVI
6437
PUT
DELISTED
Civitas Resources
CIVI
| $16K | ﹤0.01% |
125
+43
| +52% | +$8.64K |
|
6438
CALL
eHealth
EHTH
$43.5M
| $16K | ﹤0.01% |
1,300
+600
| +86% | +$6.94K |
|
6439
Vivani Medical
VANI
$113M
| $16K | ﹤0.01% |
+547
| New | +$21K |
|
|
XL
6440
PUT
DELISTED
XL Group Ltd.
XL
| $16K | ﹤0.01% |
400
-9,200
| -96% | -$361K |
|
|
HAWK
6441
PUT
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $16K | ﹤0.01% |
400
+100
| +33% | +$3.71K |
|
|
RPRX
6442
DELISTED
Repros Therapeutics Inc.
RPRX
| $16K | ﹤0.01% |
13,625
-4,520
| -25% | -$5.65K |
|
|
DRRX
6443
DELISTED
DURECT Corp
DRRX
| $15K | ﹤0.01% |
1,472
-3,285
| -69% | -$35.1K |
|
6444
PUT
Green Plains
GPRE
$1.16B
| $15K | ﹤0.01% |
600
-6,700
| -92% | -$159K |
|
6445
PUT
Hilton Grand Vacations
HGV
$4.17B
| $15K | ﹤0.01% |
+520
| New | +$14.8K |
|
6446
CALL
Unilever
UL
$142B
| $15K | ﹤0.01% |
267
-1,244
| -82% | -$62.9K |
|
|
NXGN
6447
PUT
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $15K | ﹤0.01% |
1,000
-100
| -9% | -$1.47K |
|
|
ZN
6448
DELISTED
Zion Oil & Gas, Inc.
ZN
| $15K | ﹤0.01% |
12,526
-153
| -1% | -$195 |
|
|
VVUS
6449
CALL
DELISTED
Vivus Inc
VVUS
| $15K | ﹤0.01% |
1,350
-540
| -29% | -$6.11K |
|
6450
PUT
Gerdau
GGB
$9.64B
| $14K | ﹤0.01% |
5,292
-23,058
| -81% | -$71.6K |
|
Similar funds
Goldman Sachs's Q1 2017 Portfolio in Review
As of Q1 2017, Goldman Sachs held 7,322 positions worth $369B, up 4.2% from $354B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Goldman Sachs's Q1 2017 filing shows 455 new, 2,594 increased, 3,387 reduced and 597 closed positions. Its largest new stake was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M. The largest sale was NVIDIA, an estimated $1.32B.
By sector, the portfolio is most concentrated in Financials at 9.4% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.
- Goldman Sachs's largest Q1 2017 buy was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M.
- Goldman Sachs added most to Intuitive Surgical in Q1 2017, an estimated $753M increase.
- Goldman Sachs's biggest Q1 2017 reduction was NVIDIA, cutting an estimated $1.32B.
- Goldman Sachs fully exited St Jude Medical in Q1 2017, selling an estimated $690M.
- Goldman Sachs's ten largest holdings make up 16% of its $369B portfolio in Q1 2017.
- Goldman Sachs opened 455 new positions and closed 597 in Q1 2017.
- Goldman Sachs's portfolio value rose 4.2% quarter-over-quarter to $369B.
Based on Goldman Sachs's 13F filing for Q1 2017, filed 15 May 2017.